5 Stocks To Buy That Pay A 5% Dividend Yield

BP plc (LON:BP), Centrica PLC (LON:CNA), GlaxoSmithKline plc (LON:GSK), Royal Dutch Shell Plc (LON:RDSB) and Vodafone Group Plc (LON:VOD) all yield more than 10 times today’s base rate

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I still can’t get over the fact that solid FTSE 100 players like BP (LSE: BP), Centrica (LSE: CNA), GlaxoSmithKline (LSE: GSK), Royal Dutch Shell (LSE: RDSB) and Vodafone (LSE: VOD) all now yield 5% or more… while cash gives savers a near-zero return!

Too many savers fail to realise how much income they could generate by taking a bit of extra risk with their money, plus the scope for capital growth as well. 

So which of these five stocks are your best income options?

BP

The plummeting oil price has hit BP, whose shares are down 12% in just three months. But that’s good news for income seekers, because a lower share price means a higher yield. Today, you get a juicy 5.3%.

This is riskier than leaving your money in the bank, with Deepwater Horizon legal wrangles dragging on interminably, and BP’s 20% stake in Kremlin-controlled oil enterprise Rosneft succumbing to sanctions.

If you can accept these risks, today’s valuation of just 5.6 times earnings may be a good entry point for long-term investors.

Centrica

British Gas owner Centrica offers an even more generous income of 5.8% a year. Again, a falling share price has helped, with the stock down 17% in the last year, over fears that Labour leader Ed Miliband will punish utility companies if he wins next May’s election.

But these fears are priced in, with Centrica trading at 11 times earnings, and its electric income will keep savers warm this winter.

GlaxoSmithKline

Pharmaceutical giant GlaxoSmithKline is yet another FTSE 100 income hero to stumble, its share price down 15% in six months on the Chinese bribery scandal and falling sales.

Today’s price of 12.6 times earnings looks tempting, especially since it secures you an income of 5.5% a year. And there is scope for capital growth, with profits set to flow from its R&D pipeline.

Royal Dutch Shell

Anglo-Dutch oil major Royal Dutch Shell has had a less turbulent year than BP, yet its share price is still down 9% in three months, largely on the oil price slide.

Shell is more expensive than BP, at 14 times earnings, and its dividend is slightly lower at 5%. But it pumps out cash, posting a $6.1bn profit in the second quarter alone, and looks a lot less risky than its rival right now.

Vodafone

Telecommunications giant Vodafone is another UK blue-chip going cheap, down more than 9% in six months. This really is a great time to go shopping for stocks.

Vodafone is throwing off enough cash to splurge $19 billion on its Project Spring revamp, but still has enough left over to pay you a generous income of 5.52% a year.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Harvey Jones has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Fireworks display in the shape of willow at Newcastle, Co. Down , Northern Ireland at Halloween.
Investing Articles

The Anglo American share price soars to £25, but I’m not selling!

On Thursday, the Anglo American share price soared after mega-miner BHP Group made an unsolicited bid for it. But I…

Read more »

Investing Articles

Now 70p, is £1 the next stop for the Vodafone share price?

The Vodafone share price is back to 70p, but it's a long way short of the 97p it hit in…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

If I’d put £5,000 in Nvidia stock at the start of 2024, here’s what I’d have now

Nvidia stock was a massive winner in 2023 as the AI chipmaker’s profits surged across the year. How has it…

Read more »

Light bulb with growing tree.
Investing Articles

3 top investment trusts that ‘green’ up my Stocks and Shares ISA

I’ll be buying more of these investment trusts for my Stocks and Shares ISA given the sustainable and stable returns…

Read more »

Investing Articles

8.6% or 7.2%? Does the Legal & General or Aviva dividend look better?

The Aviva dividend tempts our writer. But so does the payout from Legal & General. Here he explains why he'd…

Read more »

a couple embrace in front of their new home
Investing Articles

Are Persimmon shares a bargain hiding in plain sight?

Persimmon shares have struggled in 2024, so far. But today's trading update suggests sentiment in the housing market's already improving.

Read more »

Market Movers

Here’s why the Unilever share price is soaring after Q1 earnings

Stephen Wright isn’t surprised to see the Unilever share price rising as the company’s Q1 results show it’s executing on…

Read more »

Investing Articles

Barclays’ share price jumps 5% on Q1 news. Will it soon be too late to buy?

The Barclays share price has been having a great time this year, as a solid Q1 gives it another boost.…

Read more »